Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
16 studies found for:    "Angiofollicular lymph hyperplasia"
Show Display Options
Rank Status Study
1 Recruiting Tocilizumab for KSHV-Associated Multicentric Castleman Disease
Conditions: Castleman Disease;   Castleman's Disease;   Giant Lymph Node Hyperplasia
Interventions: Drug: Zidovudine;   Drug: Tocilizumab;   Drug: Valganciclovir
2 Completed A Safety and Efficacy Study of CNTO 328 in Patients With B-Cell Non-Hodgkin's Lymphoma, Multiple Myeloma, or Castleman's Disease
Conditions: Lymphoma, Non-Hodgkin;   Multiple Myeloma;   Giant Lymph Node Hyperplasia
Intervention: Drug: CNTO 328
3 Active, not recruiting A Study to Evaluate the Safety of Long-term Treatment With Siltuximab in Patients With Multicentric Castleman's Disease
Condition: Multicentric Castleman's Disease
Intervention: Drug: Siltuximab
4 Terminated Rituximab in the Treatment of HIV Associated Multicentric Castleman Disease Dependent on Chemotherapy
Conditions: HIV Infections;   Giant Lymph Node Hyperplasia
Intervention: Drug: Rituximab
5 Active, not recruiting
Has Results
A Study to Evaluate the Efficacy and Safety of CNTO328 Plus Best Supportive Care in Multicentric Castleman's Disease
Condition: Multicentric Castleman's Disease
Interventions: Drug: Siltuximab;   Drug: Placebo;   Drug: Best Supportive Care (BSC)
6 Completed A Study to Provide RoActemra/Actemra (Tocilzumab) to Patients With Multicentric Castleman's Disease Who Demonstrated Benefit From Previous RoActemra/Actemra Treatment
Condition: Castleman's Disease
Intervention: Drug: tocilizumab [RoActemra/Actemra]
7 Withdrawn Valganciclovir to Treat HHV-8 Associated Multicentric Castleman's Disease
Condition: Giant Lymph Node Hyperplasia
Intervention: Drug: Valganciclovir
8 Unknown  Dose-escalation Study of Oral CX-4945
Conditions: Advanced Solid Tumors;   Breast Cancer;   Inflammatory Breast Cancer;   Castleman's Disease;   Multiple Myeloma
Intervention: Drug: CX-4945 oral formulation
9 Recruiting Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity
Condition: Giant Lymph Node Hyperplasia
Intervention:
10 Recruiting Study of Pomalidomide Combined With Modified DA-EPOCH and Rituximab in KSHV-Associated Lymphomas
Conditions: Large Cell Lymphoma Arising in KSHV-associated Multicentric Castleman Disease;   Primary Effusion Lymphoma
Interventions: Drug: Pomalidomide;   Drug: Rituximab;   Drug: Prednisone;   Drug: Etoposide;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Cyclophosphamide
11 Recruiting Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors
Conditions: Non-Hodgkin Lymphoma;   Hodgkin Lymphoma;   Kaposi Sarcoma;   Gastric Cancer;   Nasopharyngeal Cancer;   EBV;   Castleman Disease
Intervention: Drug: Nelfinavir
12 Recruiting Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection
Conditions: B-cell Adult Acute Lymphoblastic Leukemia;   B-cell Chronic Lymphocytic Leukemia;   Cutaneous B-cell Non-Hodgkin Lymphoma;   Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue;   HIV Infection;   Intraocular Lymphoma;   Multicentric Castleman Disease;   Nodal Marginal Zone B-cell Lymphoma;   Recurrent Adult Acute Lymphoblastic Leukemia;   Recurrent Adult Burkitt Lymphoma;   Recurrent Adult Diffuse Large Cell Lymphoma;   Recurrent Adult Diffuse Mixed Cell Lymphoma;   Recurrent Adult Diffuse Small Cleaved Cell Lymphoma;   Recurrent Adult Grade III Lymphomatoid Granulomatosis;   Recurrent Adult Immunoblastic Large Cell Lymphoma;   Recurrent Adult Lymphoblastic Lymphoma;   Recurrent Grade 1 Follicular Lymphoma;   Recurrent Grade 2 Follicular Lymphoma;   Recurrent Grade 3 Follicular Lymphoma;   Recurrent Mantle Cell Lymphoma;   Recurrent Marginal Zone Lymphoma;   Recurrent Small Lymphocytic Lymphoma;   Refractory Chronic Lymphocytic Leukemia;   Refractory Hairy Cell Leukemia;   Refractory Multiple Myeloma;   Small Intestine Lymphoma;   Splenic Marginal Zone Lymphoma;   Testicular Lymphoma;   Waldenström Macroglobulinemia
Interventions: Drug: ibrutinib;   Other: pharmacological study;   Other: laboratory biomarker analysis
13 Recruiting Specimen Collections From Patients With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
Conditions: HIV;   Kaposi's Sarcoma;   Lymphomas;   Multicentric Castleman's Disease;   Primary Effusion Lymphoma
Intervention:
14 Completed Suramin in Treating Patients With Refractory or Relapsed Multiple Myeloma or Castleman's Disease
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Intervention: Drug: suramin
15 Completed 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic Mastocytosis
Conditions: Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Nonneoplastic Condition;   Precancerous Condition
Intervention: Drug: tanespimycin
16 Recruiting Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
Conditions: Aids-related Malignancies;   Lymphoma;   Precancerous Condition;   Sarcoma
Interventions: Genetic: polymerase chain reaction;   Other: cytology specimen collection procedure;   Other: histological technique;   Procedure: colposcopic biopsy

Indicates status has not been verified in more than two years